Trizapedol-35mg Tirzepatide Prefilled Pen

Composition:
Main ingredient: TirzepatideOther ingredients: disodium hydrogen Tirzepatide dihydrate, propylene glycol, hydrochloric acidandlor sodium hydroxide (only as a pH regulator),mannitol, phenol and water for injection.

Indications:
Trizapedol can be used as an auxiliary drug for diet and exercise to improve the blood sugar control of adult type2 diabetes patients with diabetes.

Specifieation:
30mg/ml(prefilled injector pen)

Contraindications:
Patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasiasyndrome type2(MEN2).
Known to have severe allergies to any excipients in Tirzepatide or Trizapedol.
 

Dosage and administration
The recommended starting dose for Trizapedol (Tirzepatide) is2.5 mg, administered subcutaneously once aweek. A2.5 mg dose is used for treatment initiation and not for blood glucose control.After 4 weeks, increase the dose to 5 mg and inject subcutaneously once a week. If additional blood sugar control is required,increase the dose in increments of 2.5 mg at least 4 weeks afterthe current dose.
The maximum dose of Trizapedol (Tirzepatide) is 15 mg subcutaneous injection once a week. If a dose of medication is missed, instruct the patient to take Trizapedol (Tirzepatide) as soon as possible within4 days (96 hours) afiter the missed dose. If more than 4 days have passed, skip the missed dose and take the nextdose on the scheduled day. In cach case, patients can resume their weckly routine medication schedule. If nccessary, the weekly dosing date can be changed, as long as the time between the two doses is at Ieast3days(72 hours).